JP2023525527A5 - - Google Patents

Info

Publication number
JP2023525527A5
JP2023525527A5 JP2022568549A JP2022568549A JP2023525527A5 JP 2023525527 A5 JP2023525527 A5 JP 2023525527A5 JP 2022568549 A JP2022568549 A JP 2022568549A JP 2022568549 A JP2022568549 A JP 2022568549A JP 2023525527 A5 JP2023525527 A5 JP 2023525527A5
Authority
JP
Japan
Prior art keywords
alkyl
symptoms
independently
diseases
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022568549A
Other languages
English (en)
Japanese (ja)
Other versions
JP7677995B2 (ja
JP2023525527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031479 external-priority patent/WO2021231243A1/en
Publication of JP2023525527A publication Critical patent/JP2023525527A/ja
Publication of JP2023525527A5 publication Critical patent/JP2023525527A5/ja
Application granted granted Critical
Publication of JP7677995B2 publication Critical patent/JP7677995B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022568549A 2020-05-11 2021-05-10 ガレクチン－３の低分子阻害剤 Active JP7677995B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063022627P 2020-05-11 2020-05-11
US63/022,627 2020-05-11
PCT/US2021/031479 WO2021231243A1 (en) 2020-05-11 2021-05-10 Small molecule inhibitors of galectin-3

Publications (3)

Publication Number Publication Date
JP2023525527A JP2023525527A (ja) 2023-06-16
JP2023525527A5 true JP2023525527A5 (https=) 2024-05-20
JP7677995B2 JP7677995B2 (ja) 2025-05-15

Family

ID=76284161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568549A Active JP7677995B2 (ja) 2020-05-11 2021-05-10 ガレクチン－３の低分子阻害剤

Country Status (6)

Country Link
US (1) US12286424B2 (https=)
EP (1) EP4149939A1 (https=)
JP (1) JP7677995B2 (https=)
KR (1) KR20230009433A (https=)
CN (1) CN115551850A (https=)
WO (1) WO2021231243A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
DK2906227T3 (en) 2012-10-10 2018-12-10 Galectin Therapeutics Inc GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy
CN104755088A (zh) 2012-10-31 2015-07-01 格莱克特生物技术公司 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用
CA2970062C (en) 2015-01-30 2023-02-28 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CA3000924A1 (en) 2015-11-09 2017-05-18 Galecto Biotech Ab Novel galactoside inhibitors of galectins
KR20200015528A (ko) * 2017-05-12 2020-02-12 갈랙틴 사이언시즈, 엘엘씨 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도
EP3621973A4 (en) 2017-05-12 2021-10-27 Galectin Sciences, LLC COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF
US12269819B2 (en) * 2019-04-10 2025-04-08 Bristol-Myers Squibb Company Small molecule inhibitors of Galectin-3

Similar Documents

Publication Publication Date Title
JP2022527395A5 (https=)
JP2022527075A5 (https=)
JP2016517432A5 (https=)
CN115734966A (zh) 杂环化合物及其用途
JP2023531709A5 (https=)
JP2021523221A5 (https=)
JP2021508686A5 (https=)
JP7656669B2 (ja) マトリックスメタロプロテイナーゼ（ｍｍｐ）阻害剤及びその使用方法
JP2021527102A5 (https=)
JP2015509098A5 (https=)
RU2012144332A (ru) Циклоалкил-замещенное производное имидазола
RU2008112184A (ru) Производное тиазола
JP2019526582A5 (https=)
JP2005531609A5 (https=)
JP2010530881A5 (https=)
JP2010540555A5 (https=)
JP2023533203A5 (https=)
JP2015164972A5 (https=)
JP2023531495A5 (https=)
JP2007508238A5 (https=)
JP2022545158A5 (https=)
JP2022545159A5 (https=)
JP2017509694A5 (https=)
JP2018535235A5 (https=)
JP2025500826A5 (https=)